These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8546572)

  • 21. The management of chronic hepatitis C virus infection.
    Booth JC; Brown JL; Thomas HC
    Gut; 1995 Oct; 37(4):449-54. PubMed ID: 7489926
    [No Abstract]   [Full Text] [Related]  

  • 22. [IFN in the treatment of chronic viral hepatitis. Efficacy and tolerance of lymphoblastoid alpha interferon in HIV-negative drug addicts and associated chronic active hepatitis C].
    Acone N; B1ll'Aquila G; Magliocca M; Nigro FS; Pacifico P; Imparato L
    Clin Ter; 1994 Nov; 145(11):369-72. PubMed ID: 7534222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon alpha therapy in patients with chronic type C hepatitis: changes of serum ALT, anti-HCV & HCV-RNA.
    Cho HJ; Dong SH; Lee MS; Kim HY; Park CK; Yoo JY; Polito A; Quan S; Han JH
    Korean J Intern Med; 1992 Jan; 7(1):13-7. PubMed ID: 1282364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus updated.
    Sherlock S; Dusheiko G
    Gut; 1991 Sep; 32(9):965-7. PubMed ID: 1655592
    [No Abstract]   [Full Text] [Related]  

  • 25. [Viral hepatitis C].
    Garassini MA; Alvarado MC
    G E N; 1993; 47(4):257-73. PubMed ID: 7519574
    [No Abstract]   [Full Text] [Related]  

  • 26. [HCV-serotype and IFN response].
    Nakamura H; Kako M; Aikawa T; Mayumi M; Kanai K
    Nihon Rinsho; 1994 Jul; 52(7):1734-7. PubMed ID: 7521412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus antibody in patients with chronic autoimmune hepatitis: pitfalls in diagnosis and implications for treatment.
    Davis GL
    Mayo Clin Proc; 1991 Jun; 66(6):647-50. PubMed ID: 1646354
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatitis C virus, a causative infectious agent of non-A, non-B hepatitis: prevalence and structure--summary of a conference on hepatitis C virus as a cause of hepatocellular carcinoma.
    Tabor E; Kobayashi K
    J Natl Cancer Inst; 1992 Jan; 84(2):86-90. PubMed ID: 1346540
    [No Abstract]   [Full Text] [Related]  

  • 29. [Non-A, Non-B hepatitis: advances in diagnosis and therapy].
    Bühler H
    Schweiz Med Wochenschr; 1991 May; 121(20):721-6. PubMed ID: 1647547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical relevance of hepatitis C virus genotypes.
    Simmonds P
    Gut; 1997 Mar; 40(3):291-3. PubMed ID: 9135513
    [No Abstract]   [Full Text] [Related]  

  • 31. Interferon therapy in renal allograft recipients with chronic hepatitis C.
    Harihara Y; Kurooka Y; Yanagisawa T; Kuzuhara K; Otsubo O; Kumada H
    Transplant Proc; 1994 Aug; 26(4):2075. PubMed ID: 8066675
    [No Abstract]   [Full Text] [Related]  

  • 32. Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis.
    Tassopoulos NC; Koutelou MG; Papatheodoridis G; Polychronaki H; Delladetsima I; Giannikakis T; Todoulos A; Toliopoulos A; Hatzakis A
    Gut; 1993; 34(2 Suppl):S130-2. PubMed ID: 7686113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C: an update.
    Merican MI
    Med J Malaysia; 1992 Sep; 47(3):158-69. PubMed ID: 1283440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vertical transmission of hepatitis C virus.
    Tighe MK; Miskovitz P; Leon J
    N Engl J Med; 1994 Aug; 331(6):399-400. PubMed ID: 8074752
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-alpha 2b.
    Saracco G; Rosina F; Abate ML; Chiandussi L; Gallo V; Cerutti E; Di Napoli A; Solinas A; Deplano A; Tocco A
    Hepatology; 1993 Dec; 18(6):1300-5. PubMed ID: 7694894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C.
    Willems M; Moshage H; Fevery J; Yap SH
    Neth J Med; 1992 Aug; 41(1-2):36-43. PubMed ID: 1383840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-alpha 2b for 60 weeks.
    Reichard O; Foberg U; Frydén A; Mattsson L; Norkrans G; Sönnerborg A; Wejstål R; Yun ZB; Weiland O
    Hepatology; 1994 Feb; 19(2):280-5. PubMed ID: 7507462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepatitis C].
    Viola LA; Fernández JL
    Acta Gastroenterol Latinoam; 1992; 22(2):133-4. PubMed ID: 1338677
    [No Abstract]   [Full Text] [Related]  

  • 39. Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C.
    Lau JY; Mizokami M; Ohno T; Diamond DA; Kniffen J; Davis GL
    Lancet; 1993 Nov; 342(8881):1208-9. PubMed ID: 7901531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serodiagnosis of hepatitis C in acute and chronic liver disease in southwestern Saudi Arabia.
    Jamjoom GA; Quli SK
    J Trop Med Hyg; 1992 Dec; 95(6):428-31. PubMed ID: 1281239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.